These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23322746)

  • 1. Evaluating the use of Apo-neocarzinostatin as a cell penetrating protein.
    Moody P; Burlina F; Martin SR; Morgan RE; Offer J; Smith ME; Molloy JE; Caddick S
    Protein Eng Des Sel; 2013 Apr; 26(4):277-81. PubMed ID: 23322746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, production, and characterization of recombinant neocarzinostatin apoprotein in Escherichia coli.
    Nozaki S; Tomioka Y; Hishinuma T; Inoue M; Nagumo Y; Tsuruta LR; Hayashi K; Matsumoto T; Kato Y; Ishiwata S; Itoh K; Suzuki T; Hirama M; Mizugaki M
    J Biochem; 2002 May; 131(5):729-38. PubMed ID: 11983081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic ligands for apo-neocarzinostatin.
    Caddick S; Muskett FW; Stoneman RG; Woolfson DN
    J Am Chem Soc; 2006 Apr; 128(13):4204-5. PubMed ID: 16568976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neocarzinostatin: selective tryptophan oxidation and neocarzinostatin-chromophore binding to apo-neocarzinostatin.
    Edo K; Saito K; Matsuda Y; Akiyama-Murai Y; Mizugaki M; Koide Y; Ishida N
    Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):170-6. PubMed ID: 1828722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding to and internalization by cultured cells of neocarzinostatin and enhancement of its actions by conjugation with lipophilic styrene-maleic acid copolymer.
    Oda T; Maeda H
    Cancer Res; 1987 Jun; 47(12):3206-11. PubMed ID: 2953411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced formation of a DNA bulge structure by a molecular wedge ligand-postactivated neocarzinostatin chromophore.
    Gao X; Stassinopoulos A; Ji J; Kwon Y; Bare S; Goldberg IH
    Biochemistry; 2002 Apr; 41(16):5131-43. PubMed ID: 11955061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity transfer by CDR grafting on a nonimmunoglobulin scaffold.
    Nicaise M; Valerio-Lepiniec M; Minard P; Desmadril M
    Protein Sci; 2004 Jul; 13(7):1882-91. PubMed ID: 15169956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The acidic groups of the neocarzinostatin protein play an important role in its biological activity.
    Schönlau F; Köhnlein W; Garnett MC
    Mol Pharmacol; 1994 Jun; 45(6):1268-72. PubMed ID: 8022419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene transcription analysis of Saccharomyces cerevisiae exposed to neocarzinostatin protein-chromophore complex reveals evidence of DNA damage, a potential mechanism of resistance, and consequences of prolonged exposure.
    Schaus SE; Cavalieri D; Myers AG
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11075-80. PubMed ID: 11562456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of chromophore and apo-protein in neocarzinostatin action.
    Kappen LS; Napier MA; Goldberg IH
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):1970-4. PubMed ID: 6445563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An antitumor polypeptide antibiotic neocarzinostatin: the mode of apo-protein--chromophore interaction.
    Edo K; Saito K; Akiyama-Murai Y; Mizugaki M; Koide Y; Ishida N
    J Antibiot (Tokyo); 1988 Apr; 41(4):554-62. PubMed ID: 2967272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key interactions in neocarzinostatin, a protein of the immunoglobulin fold family.
    Valerio-Lepiniec M; Nicaise M; Adjadj E; Minard P; Desmadril M
    Protein Eng; 2002 Nov; 15(11):861-9. PubMed ID: 12538905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular metabolism and cytotoxicity of transferrin-neocarzinostatin conjugates of differing molar ratios.
    Sasaki K; Kohgo Y; Kato J; Kondo H; Niitsu Y
    Jpn J Cancer Res; 1993 Feb; 84(2):191-6. PubMed ID: 8463135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitated internalization of neocarzinostatin and its lipophilic polymer conjugate, SMANCS, into cytosol in acidic pH.
    Oda T; Sato F; Maeda H
    J Natl Cancer Inst; 1987 Dec; 79(6):1205-11. PubMed ID: 2961908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of free and conjugated neocarzinostatin activity: studies on chromophore and protein uptake using a transferrin-neocarzinostatin conjugate.
    Schönlau F; Maibücher A; Köhnlein W; Garnett MC
    Z Naturforsch C J Biosci; 1997; 52(3-4):245-54. PubMed ID: 9167276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dynamics simulations investigation of neocarzinostatin chromophore-releasing pathways from the holo-NCS protein.
    Zhao X; Wang S; Gao XF; Huang XR; Sun CC
    J Struct Biol; 2010 Jan; 169(1):14-24. PubMed ID: 19747549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structures of in vitro evolved binding sites on neocarzinostatin scaffold reveal unanticipated evolutionary pathways.
    Drevelle A; Graille M; Heyd B; Sorel I; Ulryck N; Pecorari F; Desmadril M; van Tilbeurgh H; Minard P
    J Mol Biol; 2006 Apr; 358(2):455-71. PubMed ID: 16529771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neocarzinostatin chromophore. Assignment of spectral properties and structural requirements for binding to DNA.
    Napier MA; Goldberg IH
    Mol Pharmacol; 1983 Mar; 23(2):500-10. PubMed ID: 6220205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional solution structure of apo-neocarzinostatin.
    Gao X
    J Mol Biol; 1992 May; 225(1):125-35. PubMed ID: 1533878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apo-neocarzinostatin: a protein carrier for Cu(II) glycocomplexes and Cu(II) into U937 and HT29 cell lines.
    Garcia L; Franzoni S; Mussi F; Aumont-Niçaise M; Bertrand H; Desmadril M; Pelosi G; Buschini A; Policar C
    J Inorg Biochem; 2014 Jun; 135():40-4. PubMed ID: 24657806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.